Case Report: Zoledronic acid-induced hyperprogression in oncology: a case study of RET-driven neuroendocrine carcinoma treated with Selpercatinib - Poll - MDSpire

Case Report: Zoledronic acid-induced hyperprogression in oncology: a case study of RET-driven neuroendocrine carcinoma treated with Selpercatinib

  • By

  • Junqi Liu

  • FengJiao He

  • June 4, 2026

  • 0 min

Share

Original Source(s)

Case Report: Zoledronic acid-induced hyperprogression in oncology: a case study of RET-driven neuroendocrine carcinoma treated with Selpercatinib

  • by Junqi Liu, FengJiao He

  • June 4, 2026

Related Content

A case report of splenic malignancy originating from the liver

Case Report: Dynamic TKI combination strategies for EGFR-mutant NSCLC with acquired ROS1 fusion and brain metastases

Towards ultra-fast treatments: large energy acceptance beam delivery systems and opportunities for proton beam therapy